BWA
40
-4
QRVO
61
5
ALLE
30
-7
PLD
61
-3
CNX
48
-4
CMCSA
50
-2
WY
37
-5
SJM
33
-3
CMG
61
-2
USB
42
-4
AIV
58
-2
COF
59
-3
RF
45
-6
DVA
72
-3
LOW
43
-6
SPG
56
-7
DNB
34
-4
XRAY
16
-3
MA
67
-2
MS
62
-2
BWA
40
-4
QRVO
61
5
ALLE
30
-7
PLD
61
-3
CNX
48
-4
CMCSA
50
-2
WY
37
-5
SJM
33
-3
CMG
61
-2
USB
42
-4
AIV
58
-2
COF
59
-3
RF
45
-6
DVA
72
-3
LOW
43
-6
SPG
56
-7
DNB
34
-4
XRAY
16
-3
MA
67
-2
MS
62
-2
Financhill
Back

Vanguard FTSE All-Wld ex-US ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
58

VEU
Vanguard FTSE All-Wld ex-US ETF

Last Price:
58.87
Seasonality Move:
0.8%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Buy
58
Vanguard FTSE All-Wld ex-US ETF (VEU) is a Buy

Is Vanguard FTSE All-Wld ex-US ETF a Buy, Sell or Hold?

  • The current Vanguard FTSE All-Wld ex-US ETF [VEU] share price is $58.86. The Score for VEU is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • VEU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VEU Stock Price Chart

What is Vanguard FTSE All-Wld ex-US ETF's stock price today?

  • The Vanguard FTSE All-Wld ex-US ETF share price today is $58.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VEU is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

VEU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 46.89 Sell
Chaikin Money Flow: 1997922 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.92 - 59.92) Sell
Bollinger Bands (100): (56.75 - 59.45) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

VEU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.91 Sell
20-day SMA: 59.29 Sell
50-day SMA: 58.77 Buy
200-day SMA: 55.77 Buy
8-day EMA: 58.96 Sell
20-day EMA: 59.16 Sell
50-day EMA: 58.88 Sell
200-day EMA: 56.67 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Vanguard FTSE All-Wld ex-US ETF Earnings Growth & VEU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Vanguard FTSE All-Wld ex-US ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):